Trulieve Beats Estimates As Revenues Rise 78%

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) announced its results for the quarter ended June 30, 2021, as revenue rose 78% to $215.1 million versus last year’s $120 million for the same time period. It was a sequential increase of approximately $21 million or 11%. Trulieve also beat the average analyst estimate from Yahoo Finance for $207 million. Trulieve delivered a net income of $40.9 million, an increase of 116% over last year’s $18.9 million and a sequential increase of 36%.

The company said in its MD&A filing that the increase in revenue is the result of an increase in organic growth in retail sales due to an increase in products available for purchase and overall patient count. Between June 30, 2021, and June 30, 2020, the company opened or acquired 40 dispensaries, contributing to increased retail sales year over year.

“Our performance in the second quarter was strong across all financial and operating metrics,” stated Kim Rivers, Trulieve CEO. “We have become operational in Massachusetts and West Virginia and recently won an application for one of two class 1 production licenses in Georgia. We continue to execute on our national expansion model, building our footprint both organically, with license application awards, and inorganically, with strategic acquisitions.”

Expenses Rise

Growth is becoming expensive. Trulieve said that sales and marketing expenses increased by 72% from $27.0 million for the three months ended June 30, 2020, to $46.6 million for the quarter. The increase in sales and marketing expense came from a higher headcount for the year, as the company continued to add additional dispensaries in efforts to maintain and further drive higher growth in sales and market share and expand into new markets. This increased headcount resulted in higher personnel costs, which was the primary driver for the increase year over year. General and administrative expenses for the quarter also increased by 88% to $14.9 million from $7.9 million last year. The increase in general and administrative expense is the result of entering new markets and ramping company infrastructure to support growth initiatives continued acquisitions resulting in additional transaction and integration costs, and go-forward compliance.

Cash Flow

It takes money to make money as they say. The net cash provided by operating activities was $49.2 million for the six months ended June 30, 2021, a decrease of $28.5 million, compared to $77.7 million net cash provided by operating activities during the six months ended June 30, 2020. The company said this was primarily due to increases in net working capital requirements, including inventory, as it ramps the business to support growth. Net cash used in investing activities was $136.7 million for the six months ended June 30, 2021, an increase of $90.3 million, compared to the $46.4 million net cash used in investing activities for the six months ended June 30, 2020. The increase is due to the increase of property and equipment purchases for the construction of additional dispensaries and continued expansion of our cultivation and processing facilities, as well as acquisitions completed during the period.

Net cash provided by financing activities was $230.0 million for the six months ended June 30, 2021, an increase of $202.7 million, compared to the $27.3 million net cash provided by financing activities for the six months ended June 30, 2020. “The increase was primarily due to proceeds from the closing of an underwritten, marketed public offering of 5,750,000 Subordinate Voting Shares resulting in gross proceeds, before deducting underwriting discounts and commissions and offering expenses payable by us, of $227.9 million (after giving effect to the conversion rate on April 7, 2021).” The cash and cash equivalents were $289.2 million as of June 30, 2021.

Rivers continued, “Trulieve has changed considerably since our first sale in Florida in 2016, and we are only in the beginning stages of what we know we can achieve as a company. We believe the next chapter, including the anticipated closing of the Harvest acquisition, will only continue to build on the strong foundations we have worked tirelessly to establish.”

Debra Borchardt

Debra Borchardt is the CEO, Co-Founder, and Editor-In-Chief of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Masters degree in Business Journalism from New York University.

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss This Week's Groundbreaking News

Join the thousands of subscribers who stay informed with GMR's exclusive news briefs delivered directly to your inbox every Friday afternoon.

We respect your privacy. See our privacy policy.

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

@GreenMarketRpt – 3 hours

New Report from ⁦@headset_io⁩ Says Medical Cannabis Consumers Spend More. New story from ⁦@julsaitch⁩

@GreenMarketRpt – 3 hours

Yowza. Be careful when investing in crowdfunding deals. SEC files complaint against CEO and others for…

@GreenMarketRpt – 5 hours

GMR co-founders and celebrating 4 years of entrepreneurship. It’s been a wild and crazy…

Back to Top